Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
Titel:
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
Auteur:
van de Donk, Niels W C J Minnema, Monique C van der Holt, Bronno Schjesvold, Fredrik Wu, Ka Lung Broijl, Annemiek Roeloffzen, Wilfried W H Gadisseur, Alain Pietrantuono, Giuseppe Pour, Ludek van der Velden, Vincent H J Lund, Thomas Offidani, Massimo Grasso, Mariella Giaccone, Luisa Razawy, Wida Tacchetti, Paola Mancuso, Katia Silkjaer, Trine Caers, Jo Zweegman, Sonja Hájek, Roman Benjamin, Reuben Vangsted, Annette Juul Boccadoro, Mario Gay, Francesca Sonneveld, Pieter Musto, Pellegrino